Views & Analysis New frontiers in pharma: is ‘MINT’ the next ‘BRIC’? MINT countries: what the opportunities may be for pharma and healthcare.
News NICE guidance calls for quicker diagnosis of PMOS Women with polyendocrine metabolic ovarian syndrome (PMOS) should be diagnosed sooner and be offered an annual review, according to new NICE guidance.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
